Cystic fibrosis funder awards $2.2 million

Cystic Fibrosis Foundation Therapeutics Inc. awarded $2.2 million grant to Transave to develop Arikace, antibiotic to treat lung infections in cystic fibrosis patients.

Leave a Response

Your email address will not be published. All fields are required.